IBSAX
Price
$14.48
Change
+$0.25 (+1.76%)
Updated
Sep 8 closing price
Net Assets
342.46M
PAMCX
Price
$97.33
Change
+$0.26 (+0.27%)
Updated
Sep 8 closing price
Net Assets
27.36B
Interact to see
Advertisement

IBSAX vs PAMCX

Header iconIBSAX vs PAMCX Comparison
Open Charts IBSAX vs PAMCXBanner chart's image
VY® Baron Growth A
Price$14.48
Change+$0.25 (+1.76%)
VolumeN/A
Net Assets342.46M
T. Rowe Price Mid-Cap Growth Adv
Price$97.33
Change+$0.26 (+0.27%)
VolumeN/A
Net Assets27.36B
IBSAX vs PAMCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IBSAX vs. PAMCX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBSAX is a Buy and PAMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 27.4B vs. IBSAX (342M). IBSAX pays higher dividends than PAMCX: IBSAX (0.06) vs PAMCX (0.00). IBSAX was incepted earlier than PAMCX: IBSAX (23 years) vs PAMCX (25 years). IBSAX (1.62) is less costly to investors than PAMCX (1.01). PAMCX is a more actively managed with annual turnover of: 22.60 vs. IBSAX (4.00). IBSAX has a lower initial minimum investment than PAMCX: IBSAX (0) vs PAMCX (2500). PAMCX annual gain was more profitable for investors over the last year : -3.25 vs. IBSAX (-27.14). PAMCX return over 5 years is better than : 0.49 vs. IBSAX (-32.28).
IBSAXPAMCXIBSAX / PAMCX
Total Expense Ratio1.501.01149%
Annual Report Gross Expense Ratio1.621.01160%
Fund Existence23 years25 years-
Gain YTD-27.9773.310-845%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets342M27.4B1%
Annual Yield % from dividends0.060.00-
Returns for 1 year-27.14-3.25835%
Returns for 3 years-21.5012.66-170%
Returns for 5 years-32.280.49-6,635%
Returns for 10 years-46.3424.99-185%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETIHX40.600.51
+1.27%
Eventide Healthcare & Life Sciences I
ZVNIX43.030.22
+0.51%
Zevenbergen Growth Institutional
FKIDX16.790.05
+0.30%
Fidelity Diversified Intl K6
AGTHX86.220.21
+0.24%
American Funds Growth Fund of Amer A
DNLYX62.46-0.01
-0.02%
BNY Mellon Active MidCap Y